Cargando…
Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE)
Background: AdADOSE was a 12-week, international, observational study conducted in the Middle East and Russia where patients received nifedipine gastrointestinal therapeutic system (GITS) at a daily dose of 30, 60, or 90 mg as part of an antihypertensive combination therapy. This subgroup analysis o...
Autores principales: | Motaweih, Ahmed K., Usova, Elena, Hussain, Wajid, Dello, Ziad, Petri, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720040/ https://www.ncbi.nlm.nih.gov/pubmed/26331311 http://dx.doi.org/10.3109/10641963.2015.1060986 |
Ejemplares similares
-
Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)
por: Motaweih, Ahmed K., et al.
Publicado: (2015) -
High-risk patients benefit most from nifedipine GITS–telmisartan combination
por: Aalbers, J
Publicado: (2010) -
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
por: Meredith, Peter A, et al.
Publicado: (2013) -
Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension
por: Lundy, Amber, et al.
Publicado: (2009) -
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION' database in patients with angina
por: Elliott, H L, et al.
Publicado: (2011)